Zhichang Zhang

1.2k total citations
25 papers, 421 citations indexed

About

Zhichang Zhang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhichang Zhang has authored 25 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhichang Zhang's work include Sarcoma Diagnosis and Treatment (8 papers), RNA modifications and cancer (4 papers) and Bone Tumor Diagnosis and Treatments (4 papers). Zhichang Zhang is often cited by papers focused on Sarcoma Diagnosis and Treatment (8 papers), RNA modifications and cancer (4 papers) and Bone Tumor Diagnosis and Treatments (4 papers). Zhichang Zhang collaborates with scholars based in China, Hong Kong and United States. Zhichang Zhang's co-authors include Yang Dong, Zan Shen, Shuier Zheng, Wenxi Yu, Lin Feng, Yan Zhou, Yongjie Wang, Yuxuan Wei, Jiahui Wang and Qingcheng Yang and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Cancer Letters.

In The Last Decade

Zhichang Zhang

24 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhichang Zhang China	12	265	153	95	66	52	25	421
Mengwei Yao China	11	428 1.6×	232 1.5×	95 1.0×	55 0.8×	69 1.3×	26	645
Siting Zheng China	11	263 1.0×	193 1.3×	112 1.2×	81 1.2×	97 1.9×	22	530
Yongbin Zheng China	12	204 0.8×	171 1.1×	136 1.4×	80 1.2×	44 0.8×	33	471
Naixin Liang China	11	182 0.7×	147 1.0×	136 1.4×	68 1.0×	34 0.7×	13	352
Mercedes Bermúdez Mexico	12	247 0.9×	217 1.4×	91 1.0×	39 0.6×	33 0.6×	32	484
Weihui Zeng China	15	235 0.9×	149 1.0×	62 0.7×	64 1.0×	82 1.6×	60	620
Javad Verdi Iran	10	236 0.9×	177 1.2×	60 0.6×	42 0.6×	66 1.3×	17	423
Arianna Parnigoni Italy	11	303 1.1×	113 0.7×	104 1.1×	47 0.7×	63 1.2×	17	505
D. Matthew Gianferante United States	4	302 1.1×	203 1.3×	103 1.1×	172 2.6×	54 1.0×	8	513

Countries citing papers authored by Zhichang Zhang

Since Specialization

Citations

This map shows the geographic impact of Zhichang Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhichang Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhichang Zhang more than expected).

Fields of papers citing papers by Zhichang Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhichang Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhichang Zhang. The network helps show where Zhichang Zhang may publish in the future.

Co-authorship network of co-authors of Zhichang Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhichang Zhang. A scholar is included among the top collaborators of Zhichang Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhichang Zhang. Zhichang Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Jiatong, et al.. (2025). Large language models in the management of chronic ocular diseases: a scoping review. Frontiers in Cell and Developmental Biology. 13. 1608988–1608988.

Zhou, Yan, Xianan Li, Linqing Li, et al.. (2024). An open label, phase 1b/2 trial of LVGN6051 (4-1BB agonistic antibody) combined with anlotinib for refractory soft tissue sarcoma (STS).. Journal of Clinical Oncology. 42(16_suppl). 11554–11554. 1 indexed citations

Huang, Yujing, Dongyan Cao, Yue Yang, et al.. (2024). Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis. Cellular Oncology. 47(5). 1715–1733. 7 indexed citations

Shen, Longxiang, et al.. (2023). Giant cell tumors of the distal ulna: long-term recurrence rate and functional outcomes of en bloc resection versus curettage in a multicenter study. Journal of Orthopaedic Surgery and Research. 18(1). 743–743. 2 indexed citations

Zuo, Dongqing, Junxiang Wen, Wei Sun, et al.. (2023). Reduced recurrence rate and comparable functionality after wide resection and reverse total shoulder arthroplasty with allograft-prosthetic composite versus curettage for proximal humeral giant cell tumor: a multicenter retrospective study. Journal of Shoulder and Elbow Surgery. 33(5). 1040–1049. 3 indexed citations

Zhou, Juan, Yongjie Wang, Yin Sun, et al.. (2023). Essential genes analysis reveals small ribosomal subunit protein eS28 may be a prognostic factor and potential vulnerability in osteosarcoma. Journal of bone oncology. 44. 100517–100517. 2 indexed citations

Zhang, Zhichang, Weiping Ji, Jin Huang, et al.. (2022). Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients. Clinical and Translational Medicine. 12(11). e1072–e1072. 25 indexed citations

Liu, Mengfan, Yue Chen, Wenxin Li, et al.. (2022). Manganese immunotherapy for treating osteosarcoma: Glycosylating 1V209 anchored MnO2 nanosheets prompt pro-inflammatory macrophage polarization. Nano Today. 48. 101670–101670. 17 indexed citations

Yu, Xijiao, et al.. (2021). Pictilisib Enhances the Antitumor Effect of Doxorubicin and Prevents Tumor-Mediated Bone Destruction by Blockade of PI3K/AKT Pathway. Frontiers in Oncology. 10. 615146–615146. 12 indexed citations

10.

Zhou, Chenliang, Zhichang Zhang, Yan Zhou, et al.. (2020). N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1. EBioMedicine. 59. 102955–102955. 88 indexed citations

11.

Zhou, Chenliang, Zhichang Zhang, Yan Zhou, et al.. (2020). N6-Methyladenosine Modification of the TRIM7 Positively Regulates Tumorigenesis and Chemoresistance in Osteosarcoma Through Ubiquitination of BRMS1. SSRN Electronic Journal. 4 indexed citations

12.

Wang, Yongjie, Rui Zan, Weiping Ji, et al.. (2019). Integrated Analysis of Transcriptome-Wide m ⁶ A Methylome of Osteosarcoma Stem Cells Enriched by Chemotherapy. Epigenomics. 11(15). 1693–1715. 64 indexed citations

13.

Zhang, Jing, Yuxuan Wei, Yue Gong, Yang Dong, & Zhichang Zhang. (2018). Reconstruction of iliac crest defect after autogenous harvest with bone cement and screws reduces donor site pain. BMC Musculoskeletal Disorders. 19(1). 237–237. 7 indexed citations

14.

Zhang, Zhichang, et al.. (2017). MicroRNA-16-5p Inhibits Osteoclastogenesis in Giant Cell Tumor of Bone. BioMed Research International. 2017. 1–6. 27 indexed citations

15.

Zhou, Juan, et al.. (2016). Subcutaneous Angioleiomyoma. Journal of Ultrasound in Medicine. 35(8). 1669–1673. 19 indexed citations

16.

Zheng, Shuier, Guanglei Qiao, Daliu Min, et al.. (2015). Heterogeneous expression and biological function of ubiquitin carboxy-terminal hydrolase-L1 in osteosarcoma. Cancer Letters. 359(1). 36–46. 31 indexed citations

17.

Zhang, Zhichang, et al.. (2015). Baicalein suppresses the viability of MG-63 osteosarcoma cells through inhibiting c-MYC expression via Wnt signaling pathway. Molecular and Cellular Biochemistry. 405(1-2). 187–196. 29 indexed citations

18.

Yu, Wenxi, Zhichang Zhang, Daliu Min, et al.. (2014). Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis. European Journal of Cancer. 50(6). 1125–1136. 21 indexed citations

19.

Yang, Qingcheng, Yuzhen Du, Dongdong Cheng, Zhichang Zhang, & Xinhui Du. (2013). Trichostatin A destabilizes HIF-2α through a VHL-independent but proteasome-dependent pathway in cancer cell lines and tumor xenografts. Bangladesh Journal of Pharmacology. 8(2). 1 indexed citations

20.

Yang, Qingcheng, et al.. (2012). Short-term outcomes of en bloc resection of solitary bone metastases in limbs. Medical Science Monitor. 18(11). CR648–CR655. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact